EUVIMEDEUVIMED entdecken
EditorialKommentar

Cerebral Amyloid Angiopathy Diagnostic Criteria and Risk of Overdiagnosis

Matthew B Maas iD

Stroke · 2023

DOI: 10.1161/strokeaha.123.043530 ↗

Kurz gefasst

Editorial in der Zeitschrift Stroke, 2023. Verfasst von Matthew B Maas. Beteiligte Einrichtung: Departments of Neurology and Anesthesiology, Northwestern University, Chicago, IL. Hauptthemen laut MEDLINE: Stroke, Cerebral Amyloid Angiopathy. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeCerebral Amyloid AngiopathyHumansOverdiagnosisCerebral HemorrhageMagnetic Resonance Imaging

Stichwörter der Autor:innen

Editorialsangiopathyatrial fibrillationriskstroke

Autor:innen und Institutionen

  • Departments of Neurology and Anesthesiology, Northwestern University, Chicago, IL.

ORCID-Profile: Matthew B Maas

Zitieren

APA

Maas, M. B. (2023). Cerebral Amyloid Angiopathy Diagnostic Criteria and Risk of Overdiagnosis. Stroke. https://doi.org/10.1161/strokeaha.123.043530

Vancouver

Maas MB. Cerebral Amyloid Angiopathy Diagnostic Criteria and Risk of Overdiagnosis. Stroke. 2023. doi:10.1161/strokeaha.123.043530

BibTeX
@article{Maas2023,
  author = {Maas, Matthew B},
  title = {Cerebral Amyloid Angiopathy Diagnostic Criteria and Risk of Overdiagnosis},
  journal = {Stroke},
  year = {2023},
  doi = {10.1161/strokeaha.123.043530}
}
Kostenlos starten →